Why Cervical Cancer Claims Exist at All
The core scientific theory behind talcum powder litigation is that talc particles applied to the genital area for feminine hygiene can migrate through the reproductive tract and become embedded in nearby tissue, causing chronic inflammation that plaintiffs allege can lead to cancer. Some older studies, dating back to a 1971 paper, reported finding talc particles embedded in cervical tumor tissue in addition to ovarian tumor tissue, which is the scientific basis some plaintiffs have cited for cervical cancer claims specifically, alongside uterine and endometrial cancer claims.
Based on that theory, over the years some plaintiffs who developed cervical or other gynecological cancers after long-term talc use filed claims within the broader federal talc litigation, alongside the much larger group of ovarian cancer and mesothelioma claims.
The Honest, Current Answer: Most Are Being Dismissed
It is important to be direct about where this specific claim type actually stands, because it is different from the main body of talc litigation. The federal multidistrict litigation, MDL 2738 in the District of New Jersey, was formally established to handle ovarian cancer claims specifically. Cases alleging other gynecological cancers, including cervical, uterine, and endometrial cancer, were also filed into that same MDL over time, but both sides in the litigation reached an agreement in late 2025 addressing this mismatch.
Under that agreement, roughly 1,100 cases involving non-ovarian gynecological cancer claims, representing about 1.8 percent of the MDL total, are being moved toward dismissal unless the individual plaintiff can produce a specific expert report establishing general causation, meaning scientific support that talc use can cause that particular cancer type, since the existing expert evidence developed in the MDL was built around ovarian cancer specifically and both sides agree it does not automatically extend to cervical or other gynecological cancers.
What Remains Active
This development does not affect the two much larger and more active categories of talc litigation: claims alleging the talc caused ovarian, fallopian tube, or primary peritoneal cancer, which remain the central focus of the MDL with roughly 68,000 pending cases, and separate claims alleging mesothelioma from asbestos contamination in the talc, which proceed on their own track outside this particular agreement and have produced some of the largest individual verdicts in the litigation, including a 1.5 billion dollar verdict in December 2025.
For someone specifically diagnosed with cervical cancer after talc use, this means the honest picture is not that no legal option exists, but that a general filing into the ovarian cancer MDL is unlikely to succeed without individualized expert support for that specific cancer type, which makes an early, honest conversation with an experienced attorney especially important for this particular claim category.
How to Get Legal Help
If you were diagnosed with cervical cancer and have a long history of talcum powder use, an attorney experienced in this specific litigation can evaluate whether your case has the kind of individualized expert support that could allow it to proceed, since these claims are being treated differently from the mesothelioma and ovarian cancer claims that make up the bulk of the litigation.
To follow any further developments, bookmark this page and subscribe to LawsuitWatch alerts.
Free Legal Evaluation
Do You Qualify to File a Claim?
Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.
Talcum Powder Cervical Cancer Lawsuit: The Honest Status: Frequently Asked Questions
Answers to the most common questions about this case and your legal options.
Can I file a talcum powder lawsuit for cervical cancer?
Claims alleging cervical cancer have been filed, but under a late-2025 agreement, most non-ovarian gynecological cancer claims are being moved toward dismissal from the main federal MDL unless the plaintiff can produce an individual expert report specifically supporting causation for that cancer type.
Why is cervical cancer treated differently from ovarian cancer in this litigation?
Because the federal MDL, 2738, was established specifically to handle ovarian cancer claims, and the general expert evidence developed in that litigation was built around ovarian cancer. Both sides agree it does not automatically extend to cervical or other gynecological cancers.
How many cases does this affect?
Roughly 1,100 cases involving non-ovarian gynecological cancer claims, about 1.8 percent of the total MDL, are affected by the late-2025 dismissal agreement.
Does this affect mesothelioma or ovarian cancer claims?
No. Ovarian, fallopian tube, and primary peritoneal cancer claims remain the central, active focus of the MDL, and mesothelioma claims from asbestos contamination proceed on a separate track, both unaffected by this specific agreement.
What should someone with cervical cancer and a talc use history do?
Consult an attorney experienced in this specific litigation to assess whether individualized expert evidence could support your specific claim, since a general filing is unlikely to succeed without that kind of tailored causation support.